![William J. Drasler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William J. Drasler
Directeur Technique/Scientifique/R&D chez InterValve, Inc.
Profil
William J.
Drasler currently works at InterValve, Inc., as Chief Technology Officer.
Dr. Drasler also formerly worked at Possis Medical, Inc., as Vice President-Research & Development, SCIMED Life Systems, Inc. (Minnesota), as Principal, Boston Scientific Corp., as Vice President-Applied Research, and Lake Region Manufacturing, Inc., as Vice President-Engineering.
Dr. Drasler received his graduate degree from the University of Wisconsin and doctorate degree from the University of Minnesota.
Postes actifs de William J. Drasler
Sociétés | Poste | Début |
---|---|---|
InterValve, Inc.
![]() InterValve, Inc. Medical SpecialtiesHealth Technology InterValve, Inc. operates as a medical device company which develops aortic valvuloplasty balloons for treatment of calcific aortic stenosis. Its V8 product is enhanced with leaflet hyperextension without increasing the risk of annulus over-distension. The firm also develops tools for the percutaneous and trans-apical aortic valve replacement procedure. The company was founded by Wes Pedersen, Mark Ungs, Robert S. Schwartz and Robert A. Van Tassel in 2008 and is headquartered in Plymouth, MN. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de William J. Drasler
Sociétés | Poste | Fin |
---|---|---|
SCIMED Life Systems, Inc. (Minnesota)
![]() SCIMED Life Systems, Inc. (Minnesota) Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., SCIMED Life Systems, Inc. is a company that specializes in artery cleaning angioplasty catheters. The company is based in Osseo, MN. The company was founded by Lawrence L. Horsch. SCIMED Life Systems, Inc. (Minnesota) was acquired by Boston Scientific Corp. on February 27, 1995 for $865 million. | Corporate Officer/Principal | - |
Possis Medical, Inc.
![]() Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | Directeur Technique/Scientifique/R&D | - |
Lake Region Manufacturing, Inc.
![]() Lake Region Manufacturing, Inc. Medical SpecialtiesHealth Technology Lake Region Manufacturing, Inc. manufactures medical equipments. The firm offers products such as medical, surgical, ophthalmic, veterinary instruments, drug delivery applications, endomechanical devices, and apparatus. The company was founded by Joe Fleischhacker Sr. in 1947 and is headquartered in Clarence, NY. | Directeur Technique/Scientifique/R&D | - |
BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - |
Formation de William J. Drasler
University of Wisconsin | Graduate Degree |
University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BOSTON SCIENTIFIC CORPORATION | Health Technology |
Entreprise privées | 4 |
---|---|
InterValve, Inc.
![]() InterValve, Inc. Medical SpecialtiesHealth Technology InterValve, Inc. operates as a medical device company which develops aortic valvuloplasty balloons for treatment of calcific aortic stenosis. Its V8 product is enhanced with leaflet hyperextension without increasing the risk of annulus over-distension. The firm also develops tools for the percutaneous and trans-apical aortic valve replacement procedure. The company was founded by Wes Pedersen, Mark Ungs, Robert S. Schwartz and Robert A. Van Tassel in 2008 and is headquartered in Plymouth, MN. | Health Technology |
Possis Medical, Inc.
![]() Possis Medical, Inc. Medical SpecialtiesHealth Technology Possis Medical, Inc. develops, manufactures and markets innovative medical products such as disposable catheters. It engages in the development, manufacturing and marketing of medical devices for the cardiovascular and vascular treatment markets. It's primary product is AngioJet Rheolytic Thrombectomy System, a nonsurgical, minimally invasive catheter system used for blood clot removal from native coronary arteries, leg arteries, coronary bypass grafts and AV dialysis access grafts. The company offers its system to interventional cardiologists, interventional radiologists, vascular surgeons, nephrologists and osteopaths. It also offers XMI, XMI-RX, XMI RX +, Spiroflex, XVG, Xpeedior, DVX and AVX line of catheters. The company was founded in 1952 and is headquartered in Minneapolis, MN. | Health Technology |
Lake Region Manufacturing, Inc.
![]() Lake Region Manufacturing, Inc. Medical SpecialtiesHealth Technology Lake Region Manufacturing, Inc. manufactures medical equipments. The firm offers products such as medical, surgical, ophthalmic, veterinary instruments, drug delivery applications, endomechanical devices, and apparatus. The company was founded by Joe Fleischhacker Sr. in 1947 and is headquartered in Clarence, NY. | Health Technology |
SCIMED Life Systems, Inc. (Minnesota)
![]() SCIMED Life Systems, Inc. (Minnesota) Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., SCIMED Life Systems, Inc. is a company that specializes in artery cleaning angioplasty catheters. The company is based in Osseo, MN. The company was founded by Lawrence L. Horsch. SCIMED Life Systems, Inc. (Minnesota) was acquired by Boston Scientific Corp. on February 27, 1995 for $865 million. | Health Technology |